BPA Call VA24816A0004-VA24817J5597
Award Date 9/15/17
Potential Completion Date 9/22/17
Potential Value $122K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
King of Prussia, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. The $84,601.40 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The award provides for the delivery of various immune globulin products, including CARIMUNE, PRIVIGEN, and HAEGARDA, to support healthcare services for veterans. The...
- This contract award was made by the Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company that specializes in plasma-derived and recombinant therapies. The contract, valued at $84,355.00, is a delivery order under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The award is for the supply of IMMUNE GLOBULIN CARIMUNE 6GM and PRIVIGEN 5GM, which are critical pharmaceutical products used to support...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $154,935.10 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration. The contract is for the supply of the Hereditary Angioedema treatment HAEGARDA and the intravenous...
- This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The contract, valued at $77,625.80, is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $201,482,280 and is valid through September 2026. The awarded BPA call is for...
- This federal contract award, valued at $84,601.40, was made by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The award is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract provides for the delivery of various immune globulin products, including CARIMUNE (6 grams and 12...
- This federal contract award is for the procurement of pharmaceutical products, specifically immune globulin medications, by the U.S. Department of Veterans Affairs (VA). The contract was awarded to CSL Behring L.L.C., a global biotherapeutics company, under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has a ceiling value of $102,089.00 and is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The contract is...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit pharmaceutical company, under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has a ceiling value of $91,614.50 and provides pharmaceuticals such as CARIMUNE and PRIVIGEN to VA medical facilities. The contract is not set aside and is issued against CSL Behring's existing FSS contract, which has a ceiling value of...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $157,653.45 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA), allowing VA and other federal agencies to efficiently procure specialty pharmaceuticals. The order was for...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a firm fixed price delivery order to CSL Behring L.L.C. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $132,404.92 award was made for the supply of HIZENTRA and HAEGARDA pharmaceutical products to VA medical facilities. CSL Behring, a global biotherapeutics company, has provided specialty drugs such as HAEGARDA for the treatment of hereditary...
- This federal contract award was made by the Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company, for the delivery of HAEGARDA and HIZENTRA pharmaceutical products. The contract is a Delivery Order issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract managed by the General Services Administration (GSA). The award, with a potential value of $138,799.68, is a firm fixed price contract with no set-aside designation. The...